Meta-analysisindependent cross-checkabstract checked★ key study I-BAR-132 in-depth review
Network meta-analysis of trials: surgery vs medicines for diabetes
Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta-analysis and network meta-analysis of randomized controlled trials.
Overview
De Luca et al.. Diabetes Obes Metab 2023 · PMID 37272316 · DOI 10.1111/dom.15117
Across 36 trials, weight-loss operations led to more diabetes remission and lower blood sugar than medical treatment.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Surgery vs medical therapy in T2D
- How was the study done?
NMA of RCTs
- How many people, animals or samples were studied?
36 RCTs
- What was actually found?
Surgery better
- How large was the observed effect?
not in abstract
- What do the results mean in everyday life?
Surgery helps diabetes more than medicines alone
- What are the study's limitations?
Short follow-up
- What does it say about Elawady's specific claim?
Puts relapse in context
- Do the results apply to Germany and Europe?
Applicable
- What can explicitly not be concluded from this study?
Lifelong effect
Scientific in-depth review
1. Full reference
- Authors
- De Luca et al.
- Journal
- Diabetes Obes Metab
- Year
- 2023
- Identifier
- PMID 37272316 DOI 10.1111/dom.15117
- Verification
- verified – PubMed efetch 2026-10-26 + Crossref API
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
not stated in abstract
2. Research question
How do different metabolic surgical procedures compare with non-surgical therapy for type 2 diabetes?
3. Study design and population
- Study design
- Meta-analysis – Meta-analysis and network meta-analysis of RCTs (>=52 weeks)
- Population
Patients with T2D in RCTs
- Country
Multinational
- Period
not stated in abstract
- Sample size
36 RCTs
- Inclusion and exclusion criteria
RCTs >=52 weeks comparing surgery with non-surgical therapy
4. Methods and endpoints
- Exposure / intervention
LAGB, RYGB, SG, BPD, GCP, OAGB, DJB
- Comparator
Medical/non-surgical therapy
- Endpoints
HbA1c, diabetes remission, BMI and secondary outcomes
- Statistical methods
Pairwise and network meta-analysis (Mantel-Haenszel OR)
5. Actual results
- Results
Surgery associated with significantly greater HbA1c reduction, diabetes remission and BMI reduction than medical therapy. Complete remission increased with all procedures except gastric plication. Significant HbA1c reduction with OAGB and SG in NMA.
- Absolute risks
not reported in abstract
- Authors' conclusion
MBS is an effective option for T2D in patients with obesity; long-term trials needed in some groups.
6. Strengths
- RCT-only network
7. Weaknesses
- Mostly 1-5 y follow-up
- Effect sizes not in abstract
8. Risk of bias
- Orienting tool
- AMSTAR 2
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Abstract only; overlaps with STAMPEDE, Mingrone.
9. Assessment of the statistical interpretation
Not recalculable from abstract.
10. Relevance to the specific claim
Randomised evidence that surgery outperforms medical therapy for diabetes, providing context for remission erosion.
11. Independent contrary findings
12. Transferability to Germany and Europe
International RCTs.
13. Overall methodological judgement
Supports surgery superiority.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | some concerns |
| Precision of results | moderate |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Very long-term hard outcomes.
15. Linked fact checks
- The diabetes remission achieved by bariatric surgery erodes over time (SOS: 72% at 2 years to 30.4% at 15 years; Adams: 75% to 51%). – Studies contradicting or limiting the claim